Header Logo

Connection

Katie Kompoliti to Parkinson Disease

Back to Details
This is a "connection" page, showing publications Katie Kompoliti has written about Parkinson Disease.
Katie Kompoliti
Connection Strength
1.754
Parkinson Disease
  1. Sex and Gender Differences in Parkinson's Disease. Neurol Clin. 2023 05; 41(2):371-379.
    View in: PubMed
    Score: 0.453
  2. Sialorrhea in Parkinson's disease: a review. Mov Disord. 2007 Dec; 22(16):2306-13.
    View in: PubMed
    Score: 0.158
  3. Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient. Mov Disord. 2007 Aug 15; 22(11):1630-3.
    View in: PubMed
    Score: 0.155
  4. Estrogen and Parkinson's disease. Front Biosci. 2003 May 01; 8:s391-400.
    View in: PubMed
    Score: 0.115
  5. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22.
    View in: PubMed
    Score: 0.107
  6. Menstrual-related changes in motoric function in women with Parkinson's disease. Neurology. 2000 Nov 28; 55(10):1572-5.
    View in: PubMed
    Score: 0.097
  7. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. Mov Disord. 2000 Mar; 15(2):276-9.
    View in: PubMed
    Score: 0.092
  8. "On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord. 2000 Mar; 15(2):309-12.
    View in: PubMed
    Score: 0.092
  9. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology. 2000 Jan 25; 54(2):458-62.
    View in: PubMed
    Score: 0.092
  10. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol. 1998 Jul; 55(7):957-61.
    View in: PubMed
    Score: 0.082
  11. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014 May; 71(5):543-52.
    View in: PubMed
    Score: 0.062
  12. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord. 2009 Apr 15; 24(5):635-46.
    View in: PubMed
    Score: 0.043
  13. Camptocormia associated with focal myositis in multiple-system atrophy. Mov Disord. 2006 Mar; 21(3):390-4.
    View in: PubMed
    Score: 0.035
  14. Nurr1 in Parkinson's disease and related disorders. J Comp Neurol. 2006 Jan 20; 494(3):495-514.
    View in: PubMed
    Score: 0.035
  15. Dopaminergic hypersensitivity in patients with Parkinson disease and migraine. Clin Neuropharmacol. 2004 Jan-Feb; 27(1):30-2.
    View in: PubMed
    Score: 0.030
  16. The importance of educational and psychological factors in Parkinson's disease quality of life. Eur J Neurol. 2002 Nov; 9(6):589-93.
    View in: PubMed
    Score: 0.028
  17. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002 Oct; 59(10):1541-50.
    View in: PubMed
    Score: 0.028
  18. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J Comp Neurol. 2002 Aug 26; 450(3):203-14.
    View in: PubMed
    Score: 0.027
  19. Estrogen and movement disorders. Clin Neuropharmacol. 1999 Nov-Dec; 22(6):318-26.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.